Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
PLXCompany Name
PROTALIX BIOTHERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NYSEMKTPROTALIX BIOTHERAPEUTICS INC - Price to Free Cash Flow Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
PLX - P/FCF Historical data
| Date | Free Cash Flow | Market Capitalization | Price to Free Cash Flow |
|---|---|---|---|
| 6/30/2025 | $ -3.44M | $ 121.19M | 0 |
| 3/31/2025 | $ -1.56M | $ 136.92M | 0 |
| 12/31/2024 | $ 7.39M | $ 191.18M | 25.85 |
| 9/30/2024 | $ 7.17M | $ 103.82M | 14.47 |
| 6/30/2024 | $ -4.18M | $ 68.39M | 0 |
| 3/31/2024 | $ 4.37M | $ 80.65M | 18.46 |
| 12/31/2023 | $ -2.47M | $ 100.08M | 0 |
| 9/30/2023 | $ -8.64M | $ 110.16M | 0 |
| 6/30/2023 | $ -10.56M | $ 136M | 0 |
| 3/31/2023 | $ -22.82M | $ 219.79M | 0 |
Key Performance Insights, Last 5 Years
- PROTALIX BIOTHERAPEUTICS INC's latest trailing twelve months (TTM) P/FCF stands at 0.
- Over the past 5 years, PROTALIX BIOTHERAPEUTICS INC's average P/FCF has been 19.59.
- The median P/FCF for PROTALIX BIOTHERAPEUTICS INC during this period was 18.46
- PROTALIX BIOTHERAPEUTICS INC reached its highest P/FCF over the past 5 years at 25.85.
- The lowest P/FCF recorded by PROTALIX BIOTHERAPEUTICS INC in the same timeframe 14.47
PROTALIX BIOTHERAPEUTICS INC's P/FCF vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/FCF Benchmarks
Similar metrics to P/FCF:
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Price to Sales - [Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Free Cash Flow - [Calculation] Free Cash Flow is a metric that measures the cash that remains after a company pays its operating expenses [OpEx] and capital expenditures [CapEx]. It can be calculated as Net Cash Flow from Operations [NCFO] minus capital expenditures.
Definition of Price to Free Cash Flow
[Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].Market Cap / FCF
(=) P/FCF P/FCF for PROTALIX BIOTHERAPEUTICS INC is calculated as follows: Market Cap [ $ 111.68M ] / FCF [ $ -22.65M ]
(=) P/FCF [ 0 ] PLX - Price to Free Cash Flow, Last 5 years
14.47
Minimum
Sep 30, 2024
25.85
Maximum
Dec 31, 2024
19.59
Average
18.46
Median
P/FCF Benchmark AnalysisMarket
The chart above depicts the distribution of P/FCF for companies in the Total Stock Market. The average P/FCF of the companies is 18.31 with a standard deviation of 12.92.
The following table provides additional summary stats:
P/FCF in the Market:
| filtered constituents | 2.23K |
|---|---|
| min | 0.06 |
| max | 60.45 |
| average | 18.31 |
| median | 14.73 |
| std | 12.92 |